Diabetes Spectrum, 30(3), 202210
Notably, semaglutide sublingual drops may reduce gastrointestinal side effects commonly associated with oral GLP-1 agonists, making it a more appealing option for many users
For patients previously uncontrolled with 3060 IU of basal insulin, the recommended starting dose of IGlarLixi is 30 IU (30 U of glargine and l0 mcg of lixisenatide)
Research Highlights: The weight loss medication tirzepatide significantly lowered the systolic blood pressure of nearly 500 adults who had obesity and took the medication for 36 weeks, or about eight months, in a subset of an international clinical trial
Getting the diagnosis right saves you time, money, and unnecessary worry
The detailed metabolome-level effects of L-carnitine on lipid metabolism were analysed based on results obtained using a small fish, medaka, in the current study, and the findings are expected to be valuable in developing treatment for fatty liver-related diseases in the future